🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationFDA June 2026 enforcement update — compounding pharmacies Page 18

FDA June 2026 enforcement update — compounding pharmacies

RegAffairsDC Mon, Feb 26, 2024 at 4:00 PM 366 replies 55,812 viewsPage 18 of 20
jason_paloalto
Member
212
890
Nov 2024
Palo Alto, CA
Aug 5, 2025 at 2:19 PM#86

Following on from Dr.SportsMedIN — and this may be the naive question:

Was that from a primary source or from a summary of one?

24 24tane_welly, Dr.PathRoch, mona_PHX and 21 others
Reply Quote Save Share Report
lori_vegas
Member
378
1,678
Aug 2024
Las Vegas, NV
Aug 13, 2025 at 1:29 AM#87
maya_sedona said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

This is where I part company with the consensus forming above. Filing an objection on the n=1 problem. Personal experience is genuine evidence about one person and very weak evidence about anybody else, and this thread keeps promoting the first into the second.

Last edited: Aug 13, 2025 at 3:29 AM
23 23bbq_ray_KC, oliver_london, tane_welly and 20 others
Reply Quote Save Share Report
MariaRD
Member
823
4,567
Jun 2024
New Mexico
Aug 20, 2025 at 12:35 PM#88
maya_sedona said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.

22 22maria_elpaso, anders_CPH, Dr.NutriCornell and 19 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Aug 27, 2025 at 11:37 PM#89

Moderator note: a couple of off-topic posts removed. Report rather than reply if it drifts again.

21 21SleepFixSam, PurityPaulOR, MaxMetOK and 18 others
Reply Quote Save Share Report
rachel_ABQ
Member
178
890
Dec 2024
Albuquerque, NM
Sep 4, 2025 at 10:34 AM#90

Clinical perspective, offered as context rather than as advice. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

49 24Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 46 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register